261 related articles for article (PubMed ID: 18720725)
1. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
Iun'pén V; Oliushin VE; Ulitin AIu; Maslova LN; Petrov AA
Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):6-10; discussion 10-1. PubMed ID: 18720725
[TBL] [Abstract][Full Text] [Related]
2. [Combined treatment of glyal and metastatic tumors of the brain].
Fadeev BP; Zhabina RM
Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
[TBL] [Abstract][Full Text] [Related]
4. [Results of multimodal treatment of patients with glial tumors of cerebral hemispheres].
Cheremisin VM; Gaĭdar BV; Asaturian MA; Korobkova IM; Trufanov GE; Anosov NA
Vestn Rentgenol Radiol; 1995; (4):13-5. PubMed ID: 8571528
[TBL] [Abstract][Full Text] [Related]
5. Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.
Kristof RA; Neuloh G; Hans V; Deckert M; Urbach H; Schlegel U; Simon M; Schramm J
J Neurooncol; 2002 Sep; 59(3):231-7. PubMed ID: 12241120
[TBL] [Abstract][Full Text] [Related]
6. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
7. [Association of 5-FU, CDDP and hypofractionated radiotherapy in recurrences of subtentorial astrocytomas and malignant gliomas in adults].
Bolla M; Vincent P; Benabid A; Mousseau M; de Rougemont J; Vrousos C; Kolodié H; Vincent F; Pasquier B
Bull Cancer Radiother; 1990; 77(1):53-9. PubMed ID: 8703542
[TBL] [Abstract][Full Text] [Related]
8. [Results in oligodendroglioma: postoperative radiotherapy combined with chemotherapy].
Kitahara M; Katakura R; Mashiyama S; Niizuma H; Yoshimoto T; Suzuki J; Mori T; Wada T
No Shinkei Geka; 1987 Apr; 15(4):397-403. PubMed ID: 3614532
[TBL] [Abstract][Full Text] [Related]
9. Treatment of oligodendroglioma: an update.
Paleologos NA; Cairncross JG
Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
[TBL] [Abstract][Full Text] [Related]
10. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Abrey LE; Childs BH; Paleologos N; Kaminer L; Rosenfeld S; Salzman D; Finlay JL; Gardner S; Peterson K; Hu W; Swinnen L; Bayer R; Forsyth P; Stewart D; Smith AM; Macdonald DR; Weaver S; Ramsay DA; Nimer SD; DeAngelis LM; Cairncross JG
Neuro Oncol; 2006 Apr; 8(2):183-8. PubMed ID: 16524945
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
[TBL] [Abstract][Full Text] [Related]
13. [Combined treatment with neurosurgery-radiotherapy of malignant brain tumors].
Fried H; Feyer P
Zentralbl Neurochir; 1990; 51(4):208-11. PubMed ID: 1965936
[TBL] [Abstract][Full Text] [Related]
14. [State of the art in the treatment of cerebral gliomas].
Paoletti P; Butti G; Spanu G
Minerva Med; 1992; 83(1-2):17-24. PubMed ID: 1545918
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
[TBL] [Abstract][Full Text] [Related]
16. Oligodendroglioma: clinical profile and treatment results.
Jacob R; Jyothirmayi R; Dalal Y; Nambiar U; Rajan B; Nair MK
Neurol India; 2002 Dec; 50(4):462-6. PubMed ID: 12577096
[TBL] [Abstract][Full Text] [Related]
17. Oligodendroglioma: does deferring treatment compromise outcome?
Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
[TBL] [Abstract][Full Text] [Related]
18. [Postoperative radiotherapy of supratentorial anaplastic glioma].
Wendt TG; Bacherler B; Baumer K; Rohloff R; Willich N
Strahlenther Onkol; 1986 Jun; 162(6):347-53. PubMed ID: 3738736
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the treatment of low-grade astrocytomas and oligodendrogliomas.
Levin VA
Curr Opin Oncol; 1996 May; 8(3):175-7. PubMed ID: 8804814
[TBL] [Abstract][Full Text] [Related]
20. [Results of combined therapy for brain tumors of various origin].
Korytova LI; Zhabina PM; Khazova TV; Sokurenko VP; Gopta EV; Busina EIu
Vopr Onkol; 2003; 49(5):639-42. PubMed ID: 14682139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
